Affordable Access

deepdyve-link
Publisher Website

Urinary and circulating levels of the anti-angiogenic isoform of vascular endothelial growth factor-A in patients with chronic kidney disease.

Authors
  • Kikuchi, Ryosuke1
  • Yasuda, Yoshinari2
  • Nakatochi, Masahiro3
  • Shibata, Yohei4
  • Hara, Toshiaki5
  • Suzuki, Atsuo5
  • Imaizumi, Takahiro6
  • Suzuki, Susumu4
  • Ishii, Hideki4
  • Takeshita, Kyosuke7
  • Matsushita, Tadashi8
  • Maruyama, Shoichi6
  • Murohara, Toyoaki4
  • 1 Department of Medical Technique, Nagoya University Hospital, Japan. Electronic address: [email protected] , (Japan)
  • 2 Department of CKD Initiatives/Nephrology, Nagoya University Graduate School of Medicine, Japan. Electronic address: [email protected] , (Japan)
  • 3 Statistical Analysis Section, Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Japan. , (Japan)
  • 4 Department of Cardiology, Nagoya University Graduate School of Medicine, Japan. , (Japan)
  • 5 Department of Medical Technique, Nagoya University Hospital, Japan. , (Japan)
  • 6 Department of Nephrology, Nagoya University Graduate School of Medicine, Japan. , (Japan)
  • 7 Department of Cardiology, Nagoya University Graduate School of Medicine, Japan; Department of Clinical Laboratory, Nagoya University Hospital, Japan. , (Japan)
  • 8 Department of Clinical Laboratory, Nagoya University Hospital, Japan. , (Japan)
Type
Published Article
Journal
Clinica chimica acta; international journal of clinical chemistry
Publication Date
Dec 01, 2017
Volume
475
Pages
102–108
Identifiers
DOI: 10.1016/j.cca.2017.10.014
PMID: 29055691
Source
Medline
Keywords
License
Unknown

Abstract

A low urinary VEGF-A165b level reflects renal dysfunction in the chronic kidney disease stage, while a high circulating VEGF-A165b level cannot be attributed to decreased renal clearance.

Report this publication

Statistics

Seen <100 times